Mitochondrial Open Reading Frame of the 12S rRNA Type-c (MOTS-c)

MOTS-c Compound Overview

MOTS-c is a mitochondrial-derived peptide identified by the MOTS-c designation. This page identifies the material as Mitochondrial-Derived Peptide MOTS-c, with amino acid count 16; synonyms MOTS-c. The MOTS-c identifiers distinguish this catalogue entry from similarly named compounds, fragments, modified analogues, and multi-component formulations.

Mitochondrial Peptide Research Context

The research record for MOTS-c is organized around mitochondrial-derived peptide research, cellular energy-pathway studies, peptide characterization, and analytical peptide workflows. For MOTS-c, those subjects define the literature and analytical context of this specific research peptide; they do not establish a clinical indication, administration route, or expected outcome.

Available MOTS-c Specifications

The live selector currently lists 10mg, 15mg, 20mg, 40mg for MOTS-c, supplied as 10 Vials. Each selectable MOTS-c specification retains its own SKU, displayed price, inventory record, and matched image, so the chosen option can be checked without relying on a generic dose range.

MOTS-c Identity & Composition

Record boundary: Molecular identifiers describe the named MOTS-c form; lot-specific analytical results remain in the matched COA record.

How to Read the MOTS-c COA

NOVABIO currently displays 3 matched certificate records for MOTS-c, covering 10 mg, 40 mg. The newest listed record is batch NV-MOT10-0715, tested Aug 18, 2026, with reported purity 98.86% and net content 10.76 mg. For MOTS-c, match the selected specification and batch number to the displayed certificate; results from one lot are not generalized to every variant.

Research Use Notice

This material is supplied for controlled laboratory and research use only. It is not intended for human or animal consumption, diagnosis, treatment, administration, or therapeutic use. Buyers should review the selected specification and its matched documentation before ordering.